GLOBOCAN 2022

ZIMBABWE
Number of new cases Number of deaths Number of prevalent cases
(5-year)

17 725 11 739 37 913

Statistics at a glance, 2022
Males Females Both sexes
Population 7 322 449 8 008 977 15 331 426
Incidence* Zimbabwe
Number of new cancer cases 6 505 11 220 17 725
Age-standardized incidence rate 202.5 220.5 208.0
Risk of developing cancer before the age 20.5 22.1 21.2
of 75 years (cum. risk %)
Top 3 leading cancers (ranked by Prostate Cervix uteri Cervix uteri
cases)**
Kaposi Breast Breast
sarcoma NHL Prostate
NHL
Mortality*
Number of cancer deaths 4 376 7 363 11 739

Age-standardized mortality rate 142.3 150.9 144.0

Risk of dying from cancer before the age 14.4 15.9 15.2
of 75 years (cum. risk %)
Top 3 leading cancers (ranked by Prostate Cervix uteri Cervix uteri
deaths)**
Oesophagus Breast Breast
Kaposi Oesophagus Prostate
sarcoma

Prevalence*
Kilometers

0 250 500 1000

5-year prevalent cases 12 735 25 178 37 913

Top 5 most frequent cancers**

Males Females Both sexes

Cervix uteri
Prostate
Cervix uteri

Others
Others
Others
Breast

Kaposi sarcoma

Prostate

Breast
NHL Stomach
Kaposi sarcoma
Liver Oesophagus Oesophagus NHL
NHL

Total: 6 505 Total: 11 220 Total: 17 725

Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent Rank Cancer site Number of cases Percent

1st Prostate 1 707 26.2% 1st Cervix uteri 3 520 31.4% 1st Cervix uteri 3 520 19.9%

2nd Kaposi sarcoma 672 10.3% 2nd Breast 1 807 16.1% 2nd Breast 1 807 10.2%

3rd NHL 526 8.1% 3rd NHL 544 4.8% 3rd Prostate 1 707 9.6%

4th Oesophagus 423 6.5% 4th Oesophagus 467 4.2% 4th Kaposi sarcoma 1 101 6.2%

5th Liver 353 5.4% 5th Stomach 460 4.1% 5th NHL 1 070 6.0%

- Others 2 824 43.4% - Others 4 422 39.4% - Others 8 520 48.1%

Number of new cases in 2022, males, all ages Number of new cases in 2022, females, all ages Number of new cases in 2022, both sexes, all ages

The Global Cancer Observatory | All rights reserved | Globocan 2022 - 08.02.2024 Page 1
 Incidence, Mortality and Prevalence by cancer site

New cases Deaths 5-year prevalence

Cancer Number Rank (%) Cum.risk Number Rank (%) Cum.risk Number Prop. (per 100 000)

Cervix uteri 3 520 1 19.9 7.4 2 318 1 19.7 5.4 8 447 22.3

Breast 1 807 2 10.2 4.0 915 2 7.8 2.1 4 376 11.5

Prostate 1 707 3 9.6 7.6 887 3 7.6 3.7 3 049 8.0

Kaposi sarcoma 1 101 4 6.2 0.89 656 6 5.6 0.51 2 411 6.4

NHL 1 070 5 6.0 1.1 724 5 6.2 0.78 2 809 7.4

Oesophagus 890 6 5.0 1.5 837 4 7.1 1.4 1 313 3.5

Colorectum 773 7 4.4 1.2 524 9 4.5 0.78 1 724 4.5

Stomach 751 8 4.2 1.2 648 7 5.5 1.1 1 124 3.0

Liver 640 9 3.6 0.88 596 8 5.1 0.86 925 2.4

Lung 431 10 2.4 0.71 394 10 3.4 0.66 592 1.6

Corpus uteri 339 11 1.9 0.94 108 16 0.92 0.26 852 2.2

Ovary 321 12 1.8 0.74 228 12 1.9 0.59 680 1.8

Leukaemia 289 13 1.6 0.26 231 11 2.0 0.24 689 1.8

Multiple myeloma 260 14 1.5 0.45 220 13 1.9 0.39 566 1.5

Brain CNS 231 15 1.3 0.22 199 14 1.7 0.21 679 1.8

Pancreas 200 16 1.1 0.31 188 15 1.6 0.30 213 0.56

Bladder 199 17 1.1 0.32 102 18 0.87 0.16 464 1.2

Melanoma 163 18 0.92 0.26 69 20 0.59 0.11 415 1.1

Thyroid 158 19 0.89 0.24 43 24 0.37 0.05 363 0.96

Kidney 154 20 0.87 0.16 103 17 0.88 0.12 381 1.0

Vulva 147 21 0.83 0.25 80 19 0.68 0.17 385 1.0

Lip, oral cavity 113 22 0.64 0.17 66 21 0.56 0.11 256 0.68

Penis 112 23 0.63 0.33 49 23 0.42 0.14 277 0.73

Hodgkin lymphoma 98 24 0.55 0.07 40 25 0.34 0.04 280 0.74

Larynx 89 25 0.50 0.16 59 22 0.50 0.11 215 0.57

Nasopharynx 55 26 0.31 0.06 39 26 0.33 0.05 139 0.37

Gallbladder 49 27 0.28 0.07 38 27 0.32 0.06 71 0.19

Salivary glands 48 28 0.27 0.06 23 29 0.20 0.04 124 0.33

Vagina 46 29 0.26 0.08 26 28 0.22 0.05 93 0.25

Oropharynx 21 30 0.12 0.03 14 30 0.12 0.02 47 0.12

Testis 11 31 0.06 0.02 4 32 0.03 0.01 33 0.09

Hypopharynx 9 32 0.05 0.02 7 31 0.06 0.03 12 0.03

All cancers 17 725 - - 21.2 11 739 - - 15.2 37 913 -

All cancers excl. NMSC 17 312 - - 20.7 11 599 - - 15.0 36 824 -

Data source and methods

Incidence Incidence Mortality Males Females

Country-specific data source: Bulawayo cancer registry, Prostate 68.3 37.2 Prostate 68.3

Harare City cancer registry 68.2 47.9 68.2

Cervix uteri Cervix uteri

Method: Weighted/simple average of the most recent sub-

Breast 35.8 18.6 Breast 35.8
national rates applied to 2022 population
Oesophagus 12.0 11.5 Oesophagus 14.8 10.5

Mortality Stomach

NHL
10.3

10.3
9.1

7.4
Kaposi sarcoma

NHL
13.6

11.8
6.4

9.2

Country-specific data source: No data Colorectum 9.7 6.8 Colorectum 10.8 9.1

Method: Estimated from national mortality estimates by

Kaposi sarcoma 9.5 5.5 Stomach 10.4 10.2
modelling, using mortality:incidence ratios derived from survival
Liver 7.7 7.4 Liver 10.1 6.1
estimation

Corpus uteri 7.7 2.5 Lung 9.2 3.9

Prevalence Ovary 6.5 5.0 Corpus uteri 7.7

Lung 5.9 5.5 Ovary 6.5

Computed using sex-; site- and age-specific incidence to 1-;3-

Multiple myeloma 3.5 3.1 Pancreas 3.4 2.3
and 5-year prevalence ratios from Nordic countries for the period

Penis 3.0 1.4 Bladder 3.3 2.4

(2011-2020), and scaled using Human Development Index (HDI)

ratios. Pancreas 2.7 2.6 Multiple myeloma 3.2 3.8

100 80 60 40 20 0 20 40 60 80 100 100 80 60 40 20 0 20 40 60 80 100

ASR (World) incidence and mortality rates, top 15 cancers** ASR (World) incidence rates per sex, top 15 cancers**

Page 2

* includes non-melanoma skin cancer (NMSC)

** NMSC included in other cancers

Age standardization using world population (see link)

References
Cancer incidence and mortality data
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020:

Website citation GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.

2021 Feb 4. doi: 10.3322/caac.21660. Epub ahead of print. PMID: 33538338.

Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F (2024).

Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Available
Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020:
from: https://gco.iarc.who.int/today, accessed [DD Month YYYY].
An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.

© IARC 1965-2024 | All Rights Reserved | https://gco.iarc.who.int | https://gco.iarc.who.int/today